SCHEMBL8167409

SCHEMBL8167409

COc1ccc(C2(O)CCN(CCCn3c4ccccc4c4ccccc43)CC2C)cc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A1 P30531 2/20 0.72
SLC6A12 P48065 2/20 0.72
SLC6A11 P48066 2/20 0.72
SMPD1 P17405 4/20 0.55
SLC6A13 Q9NSD5 1/20 0.54
SIGMAR1 Q99720 3/20 0.48
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
ALDH1A1 P00352 2/20 0.47
SCARB1 Q8WTV0 2/20 0.47
TP53 P04637 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
ALOX15 P16050 1/20 0.47
TSHR P16473 1/20 0.47
HTR2A P28223 1/20 0.47
HTR2C P28335 1/20 0.47
MAPK1 P28482 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8176712 0.99 SLC6A1 (0.70) SLC6A1SLC6A12SLC6A11SMPD1SLC6A13
SCHEMBL8182586 0.84 SLC6A1 (1.00) SLC6A1SLC6A12SLC6A11SMPD1SLC6A13
Hydrochloric Acid SCHEMBL8175474 0.83 SLC6A1 (0.98) SLC6A1SLC6A12SLC6A11SMPD1SLC6A13
SCHEMBL8174686 0.74 SLC6A1 (0.80) SLC6A1SLC6A12SLC6A11SMPD1SLC6A13
SCHEMBL6263349 0.71 SMPD1 (1.00) SLC6A1SLC6A12SLC6A11SMPD1SIGMAR1
SCHEMBL4293184 0.70 SLC6A1 (1.00) SLC6A1SLC6A12SLC6A11SMPD1SLC6A13
SCHEMBL29462287 0.70 SLC6A1 (1.00) SLC6A1SLC6A12SLC6A11SMPD1SLC6A13
SCHEMBL8174303 0.70 SLC6A1 (0.76) SLC6A1SLC6A12SLC6A11SLC6A13SIGMAR1
Hydrochloric Acid SCHEMBL30286393 0.70 SLC6A1 (0.98) SLC6A1SLC6A12SLC6A11SLC6A13SIGMAR1
Hydrochloric Acid SCHEMBL8178596 0.70 SLC6A1 (0.98) SLC6A1SLC6A12SLC6A11SLC6A13SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6071932-A SUPPRESSING ABSORPTION OF GAMMA-AMINOBUTYRIC ACID FOR TREATMENT OF NERVOUS SYSTEM DISORDERS BRITISH TECHNOLOGY GROUP INTERCORPORATE LICENSING LIMITED (GB) 2000-06-06 US claimed
EP-0823905-A1 NOVEL HETEROCYCLIC CHEMISTRY NOVO NORDISK A/S (DK) 1998-02-18 EP claimed
WO-1996034863-A1 NOVEL HETEROCYCLIC CHEMISTRY NOVO NORDISK A/S (DK) 1996-11-07 WO claimed